Pfizer Says Celebrex Will Weather Generic Mobic
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer maintains that it is "optimistic" about the future of Celebrex (celecoxib) despite the launch of generic Mobic (meloxicam) July 19
You may also be interested in...
Mobic Faces A Baker’s Dozen Of Generic Meloxicam Following ANDA Approvals
Roxane immediately launched an authorized generic of Boehringer Ingelheim’s osteoarthritis therapy.
Mobic Faces A Baker’s Dozen Of Generic Meloxicam Following ANDA Approvals
Roxane immediately launched an authorized generic of Boehringer Ingelheim’s osteoarthritis therapy.
Celebrex On The “Rebound,” Pfizer Says
Celebrex has nearly regained the market share it lost during the COX-2 inhibitor safety controversy, Pfizer said Jan. 19